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Bacteriophages are estimated to be the most abundant entities on earth and can be found
in every niche where their bacterial hosts reside.The initial interaction between phages and
Campylobacter jejuni, a common colonizer of poultry intestines and a major source of food-
borne bacterial gastroenteritis in humans, is not well understood. Recently, we isolated and
characterized a phage F336 resistant variant of C. jejuni NCTC11168 called 11168R. Com-
parisons of 11168R with the wildtype lead to the identification of a novel phage receptor,
the phase variable O-methyl phosphoramidate (MeOPN) moiety of the C. jejuni capsu-
lar polysaccharide (CPS). In this study we demonstrate that the 11168R strain has gained
cross-resistance to four other phages in our collection (F198, F287, F303, and F326). The
reduced plaquing efficiencies suggested that MeOPN is recognized as a receptor by sev-
eral phages infecting C. jejuni.To further explore the role of CPS modifications in C. jejuni
phage recognition and infectivity, we tested the ability of F198, F287, F303, F326, and
F336 to infect different CPS variants of NCTC11168, including defined CPS mutants.These
strains were characterized by high-resolution magic angle spinning NMR spectroscopy.We
found that in addition to MeOPN, the phase variable 3-O-Me and 6-O-Me groups of the
NCTC11168 CPS structure may influence the plaquing efficiencies of the phages. Further-
more, co-infection of chickens with both C. jejuni NCTC11168 and phage F336 resulted in
selection of resistant C. jejuni bacteria, which either lack MeOPN or gain 6-O-Me groups
on their surface, demonstrating that resistance can be acquired in vivo. In summary, we
have shown that phase variable CPS structures modulate phage infectivity in C. jejuni and
suggest that the constant phage predation in the avian gut selects for changes in these
structures leading to a continuing phage–host co-evolution.
Keywords: bacteriophage, Campylobacter jejuni, capsular polysaccharide, phase variation, phosphoramidate,
methylation
INTRODUCTION
Bacteriophages (phages) are the most abundant group of organ-
isms on the planet and are estimated to outnumber their bacterial
hosts by 10-fold (Brüssow and Hendrix, 2002). The first step of
phage infection is through the specific recognition and attach-
ment of the phage particle to the host cell (Weinbauer, 2004).
In general, phages bind to unique host-specific structures, thus
allowing them to recognize a suitable host in a mixed bacterial
population (Rakhuba et al., 2010). Knowledge of phage recep-
tors is required for implementation of efficient phage therapies
against human pathogens – an intervention strategy that has been
Abbreviations: β-D-Rib, ribose; β-D-GalfNAc, N -acetylgalactosamine in the
furanose configuration; α-d-GlcpA6(NGro), glucuronic acid with 2-amino-2-
deoxyglycerol at C-6; MeOPN, O-methyl phosphoramidate; Hepp, heptose. The
2-amino-2-deoxyglycerol can also be substituted with an N -ethanolamine modifi-
cation at C-6.
promoted by the increasing occurrence of antibiotic resistance
(Levy and Marshall, 2004; Kutateladze and Adamia, 2010), yet
only a few bacterial phage receptors have been identified in Gram-
negative bacteria (for example, Gemski and Stocker, 1967; Stirm
andFreund-Molbert, 1971;Gemski et al., 1975;Yu andMizushima,
1982; Morona et al., 1984).
Capsular polysaccharides (CPS) are highly hydrated polymeric
gels that provide a thick (400 nm or more) layer protecting bacte-
ria from hostile environments and host immune defenses, but the
CPS can also be a target for phage binding and infection (Stirm
and Freund-Molbert, 1971; Roberts, 1996; Comstock and Kasper,
2006). The capsule of the zoonotic foodborne pathogen, Campy-
lobacter jejuni, is required for serum resistance, invasion of human
epithelial cells, colonization of chickens, and diarrheal disease in
ferrets (Bacon et al., 2001; Jones et al., 2004). Furthermore, muta-
tion of several C. jejuni CPS genes resulted in phage resistance
against a groupof phages,but the actual capsularmoieties involved
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2012 | Volume 2 | Article 11 | 1
Sørensen et al. Phase variable CPS in phage infection
were not identified (Coward et al., 2006). Only recently a specific
component of the C. jejuni capsule was identified as the phage
receptor for this species. We showed that phage F336 relies on
the O-methyl phosphoramidate (MeOPN) modification of the C.
jejuni NCTC11168 CPS for adsorption to the host cell surface and
infection (Sørensen et al., 2011).
The CPS of C. jejuni is the major component recognized by
the Penner serotyping scheme for which 47 different serotypes are
known (Guerry et al., 2012). Thus, the CPS are highly diverse in
structure and this is reflected by the gene content of the cap-
sular loci in various C. jejuni strains (Karlyshev et al., 2005).
In addition, a number of CPS genes possess homopolymeric
tracts making them prone to phase variation which allows a
rapid on/off switching of the genes and promotes variations in
CPS even when the strains have identical gene contents (Lin-
ton et al., 2001; St Michael et al., 2002; Karlyshev et al., 2005;
McNally et al., 2005; Chen et al., 2008). The CPS of C. jejuni
11168 consists of -2)-β-d-Ribf-(1-5)-3-MeOPN-β-d-GalfNAc-(1-
4)-α-d-GlcpA6(NGro)-(1-backbone with a 3,6-di-O-methyl-4-
MeOPN-d-glycero-α-l-gluco-Hepp side chain (St Michael et al.,
2002; Szymanski et al., 2003; McNally et al., 2005). The CPS
biosynthetic locus in strain NCTC11168 includes 28 genes and
6 of these genes (cj1420, cj1421, cj1422, cj1426, cj1429, and cj1437 )
contain homopolymeric G (polyG) tracts (Parkhill et al., 2000).
Even though the function of only three out of the six gene
products has been identified, a highly variable presence/absence
of methyl, ethanolamine, aminoglycerol, and phosphoramidate
modifications of the CPS have been observed (St Michael et al.,
2002; Szymanski et al., 2003; McNally et al., 2005), suggesting
that the remaining genes could encode enzymes involved in syn-
thesis or transfer of these modifications to the CPS glycans.
Recently, the cj1421 and cj1422 genes were shown to encode
MeOPN transferases attaching MeOPN to the GalfNAc and the
Hep residues, respectively (McNally et al., 2007). Similarly, cj1426
was demonstrated to encode the 6-O-Me transferase enzyme
(Sternberg et al., submitted).
We previously discovered that resistance toward phage F336
evolved with a high frequency in C. jejuni NCTC11168 due to
loss of the MeOPN receptor on the bacterial surface as a result
of phase variation in the cj1421 gene encoding the MeOPN–
GalfNAc transferase. In addition, deletion of the cj1421 gene in
NCTC11168 resulted in phage resistance, proving that MeOPN
attached to GalfNAc was a receptor for phage F336 (Sørensen
et al., 2011). The aim of the present study was to determine
if other phages rely on the MeOPN moiety for infection of C.
jejuni and to explore the role of other CPS phase variable mod-
ifications for phage infection. Knowledge of phage receptors and
development of phage resistance in vivo is essential for implemen-
tation of efficient phage therapy against C. jejuni in the chicken
gut. We found that not only the MeOPN moiety, but also the
phase variable 3-O-Me and 6-O-Me groups in the CPS of C.
jejuni NCTC11168 may influence phage sensitivity. Co-infection
of chickens with C. jejuni NCTC11168 and phage F336 resulted in
bacterial acquisition of phage resistance through a loss of MeOPN
attached to GalfNAc of the capsule or the acquisition of the 6-
O-Me group. We propose that the constant exposure of C. jejuni
to naturally occurring phages in the avian gut selects for different
phase variable structures of the CPS resulting in a continuous
phage-host co-evolution.
MATERIALS AND METHODS
BACTERIAL STRAINS, MEDIA, AND GROWTH CONDITIONS
The C. jejuni strains used in this study are listed in Table 1 and
were routinely grown on blood agar Base II (Oxoid) supplemented
Table 1 | Campylobacter jejuni strains.
Serotype Description Reference
1447 HS:4c Chicken isolate Hansen et al. (2007)
NCTC12662 HS:5j Origin not known National Collection of
Type Cultures, UK
NCTC11168 (MP21) HS:2 Wild type Sørensen et al. (2011)
NCTC11168 MP24 HS:2 NCTC11168 variant passaged This study
NCTC11168 MP25 HS:2 NCTC11168 variant passaged This study
NCTC11168 MP26 HS:2 NCTC11168 variant passaged This study
NCTC11168 V26 HS:2 NCTC11168 variant Carrillo et al. (2004)
kpsM Untypeable NCTC11168 kpsM::kan does not have a capsule Karlyshev et al. (2000)
11168R Phage F336 resistant NCTC11168 Sørensen et al. (2011)
S11168R Phage-sensitive 11168R Sørensen et al. (2011)
11168H HS:2 Hypermotile NCTC11168 Jones et al. (2004)
11168HΔ1421 Loss of MeOPN on GalfNAc McNally et al. (2007)
11168HΔ1421/1422 Loss of MeOPN on GalfNAc McNally et al. (2007)
Loss of MeOPN on Hep
11168HΔ1422 Loss of MeOPN on Hep McNally et al. (2007)
11168HΔ1421/1422+1422 Loss of MeOPN on GalfNAc McNally et al., 2007
Gain of MeOPN on Hep
11168H1 11168H variant This study
Loss of 6-O-Me and MeOPN on Hep
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Table 2 | Bacteriophages.
Categorya HhaI
restriction
patternb
Origin Reference
F198 III c Broiler intestine Hansen et al. (2007)
F287 III d Duck intestine Hansen et al. (2007)
F303 III d Duck abattoir Hansen et al. (2007)
F326 III d Duck intestine Hansen et al. (2007)
F336 III b Duck intestine Hansen et al. (2007)
aCategory is based on genome size (all are 140 kb) as defined in Sails et al. (1998).
bHhaI restriction pattern as determined in Hansen et al. (2007) b, 5+2 weak
bands; c, 4 bands; d, 3 bands.
with 5% calf blood (BA) or in brain heart infusion (BHI) broth
under microaerobic conditions (6% CO2, 6% O2, 84% N2, and
4% H2) at 37˚C. For chicken experiments, bacteria were grown on
Karmali agar (Oxoid) supplemented with Campylobacter selec-
tive supplement under microaerobic conditions (10% CO2, 5%
O2, 85% N2) at 37˚C.
BACTERIOPHAGES
Bacteriophages used in this study are listed in Table 2. They all
belong to the family of Myoviridae and have genome sizes of
approximately 140 kb, but show different HhaI restriction pat-
terns. Phages were propagated on C. jejuni NCTC12662, except for
phage F336 where C. jejuni 1447 was used (Hansen et al., 2007).
Stock bacteriophages were kept in SM buffer (0.05 M Tris–Cl, pH
7.5 supplemented with 5.8 g NaCl, 2.0 g MgSO4·7H2O, and 5 ml
gelatin, 2% w/v solution) at 4˚C.
BACTERIOPHAGE PROPAGATION
Bacteriophage propagation was performed as described by
Sørensen et al. (2011) using a plate lysis method developed from
Frost et al. (1999), Hansen et al. (2007). The propagating strains
were grown overnight on blood agar Base II plates and har-
vested in BHI supplemented with 1 mM CaCl2 and 10 mM MgSO4
(CBHI). Bacterial suspensions were adjusted to an optical density
of OD600 = 0.35, incubated for 4 h at 37˚C under microaerobic
conditions,mixed with phages at a multiplicity of infection (MOI)
of 0.01 and incubated for 15 min at 37˚C to allow bacteriophage
adsorption. Subsequently, 0.6 ml of the adsorbed suspensionswere
mixed with 5 ml of NZCYM overlay agar [NZCYM (Sigma) broth
with 0.6% agar] at 45˚C and poured onto NZCYM 1.2% agar
plates. After incubation, plates with lysis were flooded with sterile
SM buffer and the phages eluted overnight with gentle shaking
at 4˚C. Phage suspensions were harvested and filtered through a
sterile 0.2 μm membrane filter.
BACTERIOPHAGE TITRATION
Bacteriophage titration was performed as previously described
(Sørensen et al., 2011). Briefly, bacterial lawns were made by
mixing 5 ml NZCYM overlay agar tempered at 45˚C with 0.5 ml
bacteria harvested in CBHI from Base II agar plates and incu-
bated for 4 h as described above and poured onto NZCYM plates.
Phage solutions were spotted manually with three times 10μl of
100–10−7 phage dilutions in SM buffer. Plates were incubated at
37˚C for 20–24 h under microaerobic conditions and the num-
ber of plaque-forming units per milliliter (PFU/ml) of undiluted
phage suspensions was calculated. Usually, phage titers of 108–
109 PFU/ml could be obtained on both the propagating strains
and C. jejuni MP21.
PLAQUE ASSAY
Susceptibility of a C. jejuni strain to the bacteriophages was per-
formed using the plaque assay protocol described under Bacterio-
phage titration and determined as the efficiency of plaquing (EOP)
in percent by dividing the PFU/ml on the test strain by the PFU/ml
on the control strain (NCTC11168) multiplied by 100. The values
represented are the mean count standard deviations derived from
two to four independent experiments.
HIGH-RESOLUTION MAGIC ANGLE SPINNING NMR SPECTROSCOPY
High-resolution magic angle spinning (HR-MAS) NMR analy-
sis of intact bacterial cells was performed as previously described
(McNally et al., 2005).
IN VIVO EXPERIMENTS
One-day-old chickens were obtained from the Poultry Research
Facility, Department of Agriculture, Food and Nutritional Sci-
ence, University of Alberta. On the day of arrival, chickens were
checked for C. jejuni colonization by cloacal swabs and divided in
groups of four chickens. On day 2, chickens were first orally gav-
aged with either 107 F336 phages in SM buffer or with SM buffer
alone. After approximately 30 min, the chickens were orally gav-
aged with a suspension containing 106 C. jejuni NCTC11168 in
PBS or with PBS alone. Six days post infection, chickens were euth-
anized and the contents from one cecum were collected aseptically.
The cecal contents were weighed and resuspended in phosphate-
buffered saline at a final concentration of 0.1 g/ml. This suspension
was subjected to 10-fold serial dilutions and plated onto Karmali
selective agar plates to determine bacterial colonization levels.
One hundred microliters of the 10−1 dilution was plated sepa-
rately onto selective plates and all resulting bacterial colonies were
pooled together. Half of this pool was used for sequencing and
phage sensitivity and the other half was used for NMR analysis.
The experiment was repeated twice with consistent results. PCR
of gene cj1421 was performed as previously described (Sørensen
et al., 2011)while sequencingwas done using the following primer:
1421-seq2-F (5′-CTCGAGTTATAAGGATATTTTAGATGAG-3′).
Gene cj1426 was PCR-amplified using the primers: 1426-PCR-
F (5′-TTGAGAATTATGATAAGATGAAGG-3′) and 1426-PCR-R
(5′-TTTCCTAAGAATTCTTTACTTTCG-3′) and then sequenced
using the primers: 1426-seq-F (5′-AAGATCCAGATAAAAGAGAT
TATTTGG-3′) and 1426-seq-R (5′-ATCAGGAGAATCAAAAA
TGATTTTTCC-3′).
RESULTS
THE MeOPN MOIETY OF THE CPS OF C. jejuni NCTC11168 IS A
RECEPTOR FOR SEVERAL PHAGES
We recently demonstrated that phage F336 requires the O-methyl
phosphoramidate (MeOPN)moiety attached to theGalfNac of the
C. jejuni NCTC11168 CPS for infection (Sørensen et al., 2011).
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Table 3 | Efficiency of plaquing (EOP) of phages related to F336 as
compared to NCTC11168.
Phage NCTC11168 11168R S11168R kpsM
F198 100a –b 82.5±24.7 –
F287 100 0.04±0.03 2300±282.8 –
F303 100 – 350±113.1 –
F326 100 0.02±0.02 11.6±6.7 –
F336 100 – 331.8±64.3 –
aEOP is calculated in percent as the PFU/ml of the phages on the test strain
divided by the PFU/ml obtained on NCTC11168 multiplied by 100.
b–No plaques formed.
In our phage collection (Hansen et al., 2007) we found that five
phages, including F336, rely on capsular moieties for infection of
C. jejuni NCTC11168, since they do not form plaques on a kpsM
capsule mutant (Table 3). In our previous study, we isolated a
phage F336 resistant NCTC11168 variant in vitro (11168R),which
lost the MeOPN attached to the GalfNAc residue due to the pres-
ence of an additional G in gene cj1421 resulting in an off version
of the gene (Sørensen et al., 2011). Here we found that 11168R
had gained cross-resistance to all of the four phages: F198, F287,
F303, and F326 (Table 3). While phages F198 and F303 did not
form plaques on C. jejuni 11168R at all, plaques were observed
with F287 and F326, but with a much lower EOP compared to
wild type NCTC11168. Hence, the MeOPN structure is impor-
tant for infection by the four other phages, although two of these
phages (F287 and F326) were able to infect a strain not express-
ing the MeOPN modification. Similar results were obtained when
screening a cj1421 MeOPN transferase deletion mutant in the
NCTC11168 wild type background (data not shown). Supporting
this, the EOP of four of these phages, including F336, were fully
restored to wild type NCTC11168 levels, while the EOP of phage
F326 was partially restored, when we tested the phages against a
11168R revertant containing an intact cj1421 gene and returned
expression of the CPS MeOPN (C. jejuni S11168R; Sørensen et al.,
2011; Table 3). Thus, several phages rely on the MeOPN moiety
attached to the GalfNAc residue of CPS for infection of C. jejuni
NCTC11168.
THE LOCATION OF THE MeOPN ON THE CPS IS IMPORTANT FOR PHAGE
INFECTION
The MeOPN moiety of C. jejuni NCTC11168 can be attached to
the GalfNAc and the Hep residues in the CPS (McNally et al.,
2007) and we speculated that the attachment site of MeOPN may
be important for phage infection. We therefore conducted plaque
assays and determined EOPs of the five phages F198, F287, F303,
F326, and F336 on the hypermotileNCTC11168 variant 11168Has
well as on defined mutants in the cj1421 and cj1422 MeOPN trans-
ferase genes in this background and compared to the NCTC11168
wild type strain.All of these strains have previously been character-
ized byHR-MASNMRand 1H–31P heteronuclear single-quantum
correlation (HSQC) HR-MAS NMR for the presence/absence of
MeOPN in their CPS structure (McNally et al., 2007). Our results
showed that the attachment site of MeOPN in the CPS clearly
influenced the efficiency of the phages to infect a particular strain
(Figure 1). In general, all phages showed a higher EOP when
MeOPN was situated on the GalfNAc residue (Figures 1A,E) as
compared to MeOPN attached to the Hep residue in the CPS
(Figure 1C). A lower EOP obtained with MeOPN attached to the
Hep residue was further confirmed by screening a cj1421 + cj1422
deletion strain complemented with cj1422 (McNally et al., 2007)
with our five phages (Figure 1F). Interestingly, the four phages
F198, F287, F303, and F336 were not able to infect C. jejuni
11168H, which is the only strain expressing MeOPN on both
GalfNAc and Hep (Figure 1B), suggesting that two MeOPN moi-
eties may inhibit phage infection. Finally, we observed that the
presence of two other phase variable CPS modifications, the 3-O-
Me and 6-O-Me groups influenced the plaquing efficiency of the
phages.We also isolated a 11168H single colony variant (11168H1)
that by HR-MAS NMR and 1H–31P HSQC HR-MAS NMR analy-
sis showed the same CPS profile as the NCTC11168 wild type
strain (data not shown). The phage sensitivity profile observed
with this strain (Figure 1G) confirmed the results obtained with
NCTC11168 (Figure 1A). Thus, the presence of the 6-O-Me group
on the CPS reduced the plaquing efficiencies of phages F287 and
F326 (Figures 1A,E), suggesting that other phase variable CPS
modifications besides MeOPN affect phage infection.
C. jejuni PHAGES REQUIRE DIFFERENT COMBINATIONS OF PHASE
VARIABLE CPS MODIFICATIONS FOR SUCCESSFUL INFECTION
Phase variable expression of the capsular modifications in C.
jejuni NCTC11168 is well documented (Parkhill et al., 2000; St
Michael et al., 2002; Szymanski et al., 2003). Three frozen stocks
of NCTC11168 (MP24, MP25, and MP26) that had been passaged
a number of times in our laboratory were analyzed by HR-MAS
NMR and 1H–31P HSQC HR-MAS NMR (Figure 2). This analy-
sis revealed differences in the four phase variable modifications of
the CPS structure, i.e., the 3-O-Me, 6-O-Me, MeOPN-GalfNAc,
and MeOPN-Hep as compared to our NCTC11168 wild type
(Table 4). We also included another NCTC11168 variant (V26)
previously shown to have yet another different set of modifications
(St Michael et al., 2002; Carrillo et al., 2004).
Plaque assays using our five phages showed that these C. jejuni
strains had distinct phage sensitivity profiles (Figures 3B–E).
Interestingly,C. jejuni MP26 that expresses bothMeOPNmoieties,
similar to the phage-resistant C. jejuni 11168H (Figure 1B), could
be infected by four of the five phages although with different effi-
ciencies (Figure 3D). However, CPS of C. jejuni MP26 only con-
tains the 3-O-Me group, whereas 11168H CPS contains both the
3-O-Me and 6-O-Me groups (Figures 1B and 3D). These results
indicate that the presence of 6-O-Me may inhibit phage infec-
tion. This was further supported by the observation that none of
the phages formed plaques when the 3-O-Me was exchanged with
the 6-O-Me while retaining the MeOPN modification attached to
GalfNAc (Figures 3A,E). Furthermore, the presence of the 6-O-
Me group in combination with a MeOPN situated on the GalfNAc
and a 3-O-Me group clearly inhibited infection by phage F287
and F326 (Figures 1E,G). Thus, our data suggest that the 6-O-Me
group inhibits plaque formation in vitro and that all five phages
require MeOPN attached to GalfNAc together with the 3-O-Me to
obtain the most efficient infection. However, different combina-
tions of the phase variable CPS modifications appear to influence
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FIGURE 1 | Capsular polysaccharide structures expressed by defined
MeOPN transferase mutants and their affect on phage sensitivity.The
CPS structure is schematically illustrated (modified from Guerry and
Szymanski, 2008). Phage sensitivity patterns are calculated as the 1efficiency
of plaquing (EOP) as compared to plaque formation on the NCTC11168 wild
type strain. (A) NCTC11168; (B) 11168H; (C) 11168HΔ1421; (D)
11168HΔ1421/Δ1422; (E) 11168HΔ1422; (F) 11168HΔ1421/Δ1422+1422;
and (G) 11168H1. 2Plaques were only detected in one out of three
experiments. 3MeOPN detected in lower amounts due to partial
complementation. Abbreviations are: GalfNAc, N -acetylgalactosamine in the
furanose configuration; MeOPN, O-methyl phosphoramidate; Hep, heptose;
and O-Me, O-methyl.
binding of the phages differently. In particular, phage F326 showed
the lowest EOP values (Table 3; Figures 1 and 3) suggesting that
other combinations of receptors, not investigated in this study,
might be optimal for the binding of this phage.
SELECTION FOR PHAGE-RESISTANT VARIANTS DURING C. jejuni
COLONIZATION OF CHICKENS
To assess whether C. jejuni is capable of becoming resistant to bac-
teriophage F336 in vivo during colonization of chickens, we orally
gavaged 2-day-old chickens with F336 and subsequently with C.
jejuni NCTC11168. After 6 days, the chickens were euthanized and
the bacteria from the ceca were analyzed. We observed similar
levels of colonization after 6 days of infection between the groups
receiving bacteria only, as compared to those receiving bacteria
and bacteriophages (i.e., 109 CFU/g cecal content, Table 5). The
bacteria grown from the cecal contents were directly pooled from
plates and analyzed by HR-MAS NMR. All bacteria obtained from
chickens infected with C. jejuni alone showed an NMR profile that
was the same as the NMR spectrum of the inoculum: the bacte-
ria expressed one MeOPN attached to GalfNAc and the 3-O-Me
group bound to Hep. However, bacteria from the group of chick-
ens that received both bacteria and bacteriophages had lost the
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FIGURE 2 | High-resolution magic angle spinning NMR spectra showing
the differences in CPS modifications between NCTC11168 variants MP24,
MP25 and MP26. 1H CPMG spectra of intact C. jejuni cells. Abbreviations
are: Hep, D-glycero-α-L-gluco-Hep; Rib, β-D-Ribf ; GlcA, α-D-GlcpA6(NGro);
GalfNAc, β-D-GalfNAc; MeOPN, O-methyl phosphoramidate; OMe,
O-methyl; NAc, N -acetyl; TSP, trimethylsilyl propionic acid standard.
Table 4 | ppmValues for 1H HR-MAS NMR spectra for NCTC11168 variants and MeOPN transferase status.
C. jejuni strain Hepa Rib GlcA GalfNAc 3-O-Me 6-O-Me NAc MeOPN cj1421/cj1422 (GalfNAc/Hep)b
NCTC11168 MP24 5.582 5.376 5.103 5.015 3.629 3.557 2.071 3.772 −/+
NCTC11168 MP25 5.599 5.363 5.148 5.039 – 3.569 2.066 - (3.772)c −/−
NCTC11168 MP26 5.610 5.361 5.143 5.101 3.630 – 2.068 3.768/3.743 +/+
aOnly anomeric proton resonances for carbohydrate residues are listed.
bSummary of sequencing results indicating the “on” (+) and “off” (−) status of the genes encoding the MeOPN transferases onto GalfNAc (cj1421) and Hep (cj1422).
cOnly trace amounts of MeOPN detected.
MeOPN in all instances, except for one (Figure 4; Table 5). In
chicken #238, infected with phage F336 and C. jejuni, the bacteria
showed reduced levels of MeOPN present on both GalfNAc and
Hep, but the bacteria also expressed high levels of 6-O-Me on the
Hep (Figure 4).
To test whether the observed changes in CPS modifications
resulted inphage resistance,weperformedbacterial titration assays
with all of the isolates recovered from the chickens. All isolates
from the F336 infected birds had gained resistance to phage F336
and still showed similar levels of colonization (Table 5). Previ-
ously, we have shown that a loss of MeOPN on GalfNAc can be
the result of a switch in the polyG region of the MeOPN trans-
ferase gene cj1421 (Sørensen et al., 2011). To determine whether
the loss of MeOPNand subsequent phage resistancewere the result
of a switch in the polyG region, we sequenced gene cj1421 from
the pooled colonies from both experiments. All phage-sensitive
isolates showed 9 G residues in the polyG region, while all phage-
resistant isolates (except from chick 238) showed either 8 or 10
G residues in this region, which in both cases results in a non-
functional transferase, due to a premature stop codon 1 or 5
amino acids after the polyG region, respectively (data not shown).
Examination of the pooled colonies from chick 238 showed 9
G residues in the polyG region of cj1421, consistent with the
observed MeOPN expression. However, sequencing of the polyG
region of cj1426 from the pooled colonies from chick 238 showed
10 G residues indicating that the 6-O-Me transferase enzyme
was functional (again consistent with the acquired expression of
the Me modification in Figure 4) compared to 11 G residues in
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FIGURE 3 | Capsular polysaccharide structures expressed by NCTC11168
variants and the corresponding phage sensitivity profiles.The CPS
structure is schematically illustrated (modified from Guerry and Szymanski,
2008). Phage sensitivity patterns are calculated as the 1efficiency of plaquing
(EOP) as compared to plaque formation on the NCTC11168 wild type strain.
(A) NCTC11168; (B) NCTC11168 MP24; (C) NCTC11168 MP25; (D) NCTC11168
MP26; and (E) NCTC11168 V26. 2MeOPN only detected in minor amounts.
Abbreviations as above are: GalfNAc, N -acetylgalactosamine in the furanose
configuration; MeOPN, O-methyl phosphoramidate; Hep, heptose; and
O-Me, O-methyl.
the parental strain lacking this modification. Thus, C. jejuni can
become resistant to phage F336 during in vivo colonization of
chickens by changing the expression of its CPS phase variable
modifications.
DISCUSSION
Implementation of efficient phage therapies to target pathogenic
bacteria requires detailed knowledge of the bacterial receptors rec-
ognized by the phages, as this bacteria–phage interaction is the first
event in a process leading to lysis of the host organism. We pre-
viously identified the C. jejuni NCTC11168 CPS phase variable
MeOPN modification as the receptor for phage F336 (Sørensen
et al., 2011). The goal of the present study was to further explore
the role of MeOPN and other C. jejuni phase variable CPS modi-
fications, such as O-methylation in phage infection. We compared
five different phages, including F336 that were unable to pro-
liferate in an acapsular mutant of C. jejuni NCTC11168, and
determined their ability to infect NCTC11168 variants containing
the same CPS backbone sugars as NCTC11168, but with different
modifications.
We found that the phages F198, F287, F303, F326, and F336
all infected C. jejuni most efficiently when the 3-O-Me modifica-
tion on Hep and a MeOPN moiety was present, with higher EOPs
observed when the MeOPN modification was attached to GalfNAc
rather than Hep. Interestingly, when the 3-O-Me was exchanged
with the 6-O-Me while retaining the MeOPN on GalfNAc, none
of the phages formed plaques at all, demonstrating a clear role for
the O-methyl Hep modifications for phage infection, in addition
to the previously identified phage receptor, MeOPN (Sørensen
et al., 2011). By looking at the predicted three dimensional (3D)
structure of the C. jejuni NCTC11168 CPS (Guerry and Szy-
manski, 2008), it is possible that the presence or absence of one
or more CPS modifications may lead to conformational changes
that interfere with the phage binding process. Indeed it has been
found that changes in the 3D conformation of the outer mem-
brane protein OmpA, which serves as the receptor for many of the
T-even phages infecting E. coli, leads to phage resistance (Riede
and Eschbach, 1986). Furthermore, the spatial arrangement of the
modifications may be important for phage recognition and some
modifications may potentially block the phage binding site when
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Table 5 | Presence of MeOPN and phage sensitivity of C. jejuni isolated after colonization of chickens.
Infected with Bacterial counts (CFU/g) MeOPN on GalfNAc Phage sensitivitya
MP21 Inoculum NR NR + Yes
MP21 Karmali NR NR + Yes
Chick 405 MP21 5.7×109 + Yes
Chick 406 MP21 4.1×109 + Yes
Chick 407 MP21 9.9×108 + Yes
Chick 408 MP21 1.1×109 + Yes
Chick 505 MP21+F336 7.9×108 − No
Chick 506 MP21+F336 5.0×109 − No
Chick 507 MP21+F336 5.8×109 − No
Chick 508 MP21+F336 8.5×108 − No
Chick 343 MP21 2.0×109 + Yes
Chick 344 MP21 2.1×109 + Yes
Chick 345 MP21 1.6×109 + Yes
Chick 346 MP21 3.6×109 + Yes
Chick 237 MP21+F336 1.2×109 − No
Chick 238 MP21+F336 5.5×109 +b No
Chick 239 MP21+F336 4.7×109 −c No
Chick 240 MP21+F336 4.1×109 − No
Chicks 405–408 and 505–508 are from the first experiment, while chicks 343–346 and 237–240 are from the second experiment.
aYes: plaques formed on isolated strain, No: no plaques formed on isolated strain.
bBacteria isolated from this chick showed reduced MeOPN levels (of both MeOPN groups) and enhanced levels of 6-O-Me.
cMeOPN levels barely above the baseline could be detected from bacteria isolated from this chick.
NR, not relevant.
they are expressed. Certainly masking the phage binding site is a
well known resistance mechanism in other bacteria. One example
is Staphylococcus aureus that masks its phage receptor with protein
A, a cell-wall-anchored virulence factor for this bacterium (Nord-
strom and Forsgren, 1974). In agreement with this hypothesis, we
observed that when MeOPN was present on both the GalfNAc
and Hep residues together with the 3-O-Me and 6-O-Me Hep
modifications, then four of the five phages could no longer infect
that particular C. jejuni 11168 strain. Thus, both the presence and
absence of the capsular modifications appears to modulate phage
infectivity of the NCTC1168 strain.
Our results demonstrate that the phages infecting C. jejuni
are highly specific in the recognition of the CPS and that each
phage has evolved to recognize a particular combination of capsu-
lar modifications. One might speculate that the phages included
in this study originated from the same ancestral phage that has
co-evolved with C. jejuni to recognize different capsular surface
structures by minor modifications in the phage receptor binding
proteins (RBP). In support of this, sequencing of viral proteins
from the C. jejuni phage CP220 revealed at least two distinct tail
structures in the mature virions although propagated from a single
plaque (Timms et al., 2010), suggesting a possibility for the phage
to recognize multiple receptors. A similar phenomena has been
observed for capsular phages infecting E. coli (Scholl et al., 2001).
Indeed RBPs of other phages often have hypervariable regions
in the receptor recognizing domains, reflecting the ability of the
phage to easily accumulate mutations thereby changing the struc-
ture of the RBP to recognize modified receptors or new types of
receptors, such as switching from protein to carbohydrate recog-
nition (Montag et al., 1990; Drexler et al., 1991; Hashemolhosseini
et al., 1994). The C. jejuni phages investigated in this study have
similar genome sizes and morphologies and were previously iso-
lated from duck and broiler intestines and duck abattoirs (Hansen
et al., 2007). Although these phages all are able to infect the
NCTC1168 strain, they do show different host ranges for C. jejuni
strains of different Penner serotypes (Hansen et al., 2007). In addi-
tion, enzymatic restriction cleavage of the phage genomes revealed
differences among the phages (Table 2, Hansen et al., 2007). Thus,
although a conserved head and tail architecture is maintained, it is
apparent that genomic dissimilarities exist between the five phages
compared in this study and this may account for the differences in
host specificity.
In C. jejuni, the CPS are highly diverse, due to differences in
the genetic compositions of the CPS loci, but also because many
of the genes in these loci contain homopolymeric tracts making
them prone to phase variation (Linton et al., 2001; St Michael
et al., 2002; Szymanski et al., 2003; Karlyshev et al., 2005; McNally
et al., 2005; Chen et al., 2008). Based on the number of phase
variable modifications in the capsule of C. jejuni NCTC11168
alone, this may result in the expression of >700 CPS structural
variants. Our results demonstrate that phase variable CPS surface
structures clearly influence the phage attachments sites in C. jejuni
NCTC11168. Phase variable expression also affects phage adsorp-
tion in Bordetella spp. These bacteria use phase variable expression
of the BvgAS two-component regulatory system to alter their sur-
faces through the regulation of colonization and virulence factors
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FIGURE 4 | NMR analysis of intact C. jejuni cells recovered from chicken
cecal contents. (A) 1H HR-MAS NMR CPMG spectra, displaying the capsular
profile and (B) corresponding 1D 1H–31P HSQC spectra specifically
demonstrating the phosphoramidate resonances. Black arrowhead: note the
change in the GalfNAc resonance due to the absence of MeOPN. White
arrowhead: note the absence of the MeOPN specific resonance.
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and also expression of the phage BPP-1 receptor Prn (pertactin
autotransporter; Liu et al., 2002). To combat these changes, the
BPP-1 phage has a sophisticated mechanism of varying its RBP
(∼10+13 possible sequences) that approaches the levels of diver-
sity observed for immunoglobulins (Liu et al., 2002; Doulatov
et al., 2004), and the phage is thus able to overcome the resistance
by an equally efficient mechanism.
It was previously shown that CPS expression is important for
C. jejuni colonization of the chicken gut as well as being impor-
tant for interactions with human models of disease (Bacon et al.,
2001; Jones et al., 2004). Here we show for the first time that the
presence of phages selects for specific CPS variants in vivo in the
chicken gut without altering the colonization levels, even though
MeOPN expression influences C. jejuni invasion of human cells
(van Alphen, unpublished results). Thus, the roles of phase vari-
able CPS modifications, such as the MeOPN and the O-methyl
groups, may not only be linked to adaptation to the human or
chicken hosts, but may serve an important function for C. jejuni
survival in the avian gut; an environment that contains a high
number of bacteria as well as phages (Connerton et al., 2004;
Hansen et al., 2007). Scott et al. (2007) also described that certain
isolates of C. jejuni containing Mu-like prophage DNA sequences
were capable of developing bacteriophage resistance in the chicken
gut through a mechanism of reversible genomic rearrangement.
Remarkably, these isolates inverted genomic segments up to 590 kb
which also led to a decrease in chicken colonization and produc-
tion of a functional Mu-like bacteriophage (Scott et al., 2007).
The authors speculated that the development of phage resistance
could be due to alterations in the bacterial surface receptor or
through saturation of the receptor sites if the Mu phage is rec-
ognizing the same structures. Here, we have shown that phase
variable modifications of the CPS influence phage infectivity, sug-
gesting that the constant exposure of C. jejuni to phages in the
avian gut selects for changes in the phase variable structures of the
CPS leading to a continuing co-evolution of C. jejuni polysaccha-
rides and phage RBPs. This should be considered when developing
future strategies for phage therapy against C. jejuni in the chicken
host and when determining the kinetics of resistance development
and the timing for therapy administration. Since the alteration
of bacterial surface receptors that reduces or eliminates phage
adsorption to the host cell appears to be the most common mecha-
nism of phage resistance (Bohannan and Lenski, 2000), continued
investigations into the diversity of phage receptors in C. jejuni is
required to select the most efficient combinations of phages for
therapy.
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